How many steps a day for longevity: what the research actually shows

There is a number that almost every wearable nudges you toward, every wellness app celebrates when you cross, and almost no one has actually questioned: 10,000 steps a day. Turns out that target did not come from a research paper. It came from a 1965 marketing campaign for a Japanese pedometer called the Manpo-kei — literally “10,000-step meter” — and it has been quietly dictating our walking goals for sixty years for no particularly good reason.

The actual research on steps and longevity is both more recent and more interesting than the round number would suggest. And for once, the news is pretty forgiving: you probably need fewer steps than you think.

Where the 10,000 number actually came from

The Manpo-kei was launched in the mid-1960s by a Japanese company called Yamasa, timed vaguely around the 1964 Tokyo Olympics and the national interest in fitness that followed. The founder, Dr Yoshiro Hatano, did have some back-of-the-envelope calorie-balance reasoning behind the choice — a typical Japanese adult burned about 2,000 kcal daily, and 10,000 steps roughly accounted for the activity component — but this was marketing maths, not epidemiology.

It stuck because the Japanese character for 10,000 (万) visually resembles a person walking, which made the logo design elegant. That is genuinely part of why the number is what it is. A slightly absurd origin story for something that has shaped six decades of public health messaging.

For most of the time since, the 10,000 figure lived on as conventional wisdom without anyone running proper dose-response studies on it. Step-counting research required actually tracking large numbers of people for years with accurate devices, and that only became practical in the last decade. The research we now have is, predictably, more nuanced than a round marketing number.

What the actual longevity research shows

The turning point for step-count research was roughly 2019 onwards, when accelerometer-wearing cohorts got big enough and followed long enough to produce real mortality data. Three studies are worth knowing, because they form the backbone of current guidance.

The first is the Saint-Maurice analysis from 2020, published in JAMA — a study of around 4,800 American adults aged 40 and over who wore research-grade accelerometers for a week and were then followed for about a decade. Saint-Maurice and colleagues at the NIH found that compared to participants taking 4,000 steps per day, those taking 8,000 steps had a 51% lower all-cause mortality risk. Twelve thousand steps reduced it further, but the curve was clearly bending.

The second is the Paluch meta-analysis from 2022, published in The Lancet Public Health — a pooled analysis of fifteen studies covering roughly 47,000 adults worldwide. This is the one worth paying attention to if you want a global picture. Paluch and the Steps for Health Collaborative found a clear dose-response relationship up to about 6,000-8,000 steps for older adults and 8,000-10,000 for younger adults, after which the benefit plateaued. Critically, there was no harm signal beyond 10,000 — just flat returns.

The third is the del Pozo Cruz analysis from 2022, also in JAMA Internal Medicine, using UK Biobank data from around 78,500 adults with wrist-worn accelerometers. Del Pozo Cruz and colleagues found every 2,000-step increment up to about 10,000 was associated with lower mortality and lower cancer and cardiovascular disease risk. They also looked at cadence — walking pace — and found that higher cadence added independent benefit on top of raw volume, although the effect was smaller than the volume effect.

Three different research groups. Different populations. Different devices. Broadly the same answer: most of the benefit arrives between 4,000 and 8,000 steps per day, the curve flattens around 8,000-10,000, and after that you’re mostly just collecting extra steps because your watch likes you to.

The dose-response curve, in plain English

If you plotted mortality risk against daily steps from these studies, you would not see a straight line. You would see something like a ski slope that flattens out near the bottom. Going from 2,000 to 4,000 steps buys you a huge relative risk reduction. Going from 4,000 to 8,000 buys you a substantial but smaller reduction. Going from 8,000 to 12,000 buys you a modest further reduction, and going from 12,000 to 16,000 buys you almost nothing measurable.

This shape matters because it changes the practical advice. If you’re at 3,000 steps a day, adding 2,000 is genuinely life-changing on a population level. If you’re at 9,000, adding 2,000 more is… nice, but not really the lever you should be pulling. The public health win is dragging sedentary people up to moderate activity, not pushing already-active people to do more.

It also means that 7,000 — a number that sounds arbitrary and slightly disappointing — is probably the most defensible round figure if you wanted to replace 10,000 with something evidence-based. Which, aesthetically, is a shame. Seven thousand does not have the same ring to it.

Cadence, or: why pace matters too

The del Pozo Cruz paper made step cadence fashionable in longevity circles, and for good reason. Researchers found that people walking at a cadence of around 100 steps per minute or higher had additional cardiovascular benefit beyond their total volume. In practice, 100 steps per minute is a brisk walk — moving with purpose, not strolling and looking at shop windows.

This is where steps start overlapping with structured cardio. A brisk walk for most untrained adults produces a heart rate response that fits comfortably into Zone 2 — the sweet spot for mitochondrial adaptations and aerobic base-building. So if you take your 7,000 steps at a decent clip, you’re not just collecting volume, you’re doing low-intensity aerobic training without calling it that.

The flip side: 7,000 very slow, shuffling steps are not the same as 7,000 brisk ones. The accelerometer can’t tell the difference between ambling and striding, and neither can your step counter. Cadence does most of the qualitative work.

Steps vs structured exercise

This is the question that comes up repeatedly in the Sarvita app’s feedback: is walking enough, or do I still need to do proper training? The honest answer is that walking is genuinely foundational and genuinely incomplete.

What walking does well: it accumulates low-intensity cardiovascular load, improves insulin sensitivity, supports metabolic flexibility, and gets you outdoors — which feeds sleep and mood in ways that are hard to measure but clearly matter. If you’re walking 7,000-8,000 steps at a decent pace most days, you’ve covered most of the “move your body regularly” requirement.

What walking does not do, at least not efficiently: build VO2 Max past moderate levels, stimulate meaningful muscle hypertrophy, or produce the high-intensity cardiovascular stress that drives peak aerobic capacity. For those, you need short bouts of harder work — intervals, hills, or sport — and separate resistance training.

A 2023 meta-analysis in the British Journal of Sports Medicine looked at this directly and found that while daily step count was strongly associated with all-cause mortality, adding structured moderate-to-vigorous activity on top of steps produced additional benefit, particularly for cardiovascular endpoints. Both matter. They are not interchangeable. But steps are the base layer, and without that layer the structured training sits on top of a weaker foundation.

What about age?

The Paluch meta-analysis split its results by age, and the split is genuinely useful. For adults under 60, the mortality curve continued improving up to around 8,000-10,000 steps. For adults over 60, the curve plateaued earlier — around 6,000-8,000. This is consistent with the general pattern that older bodies gain more from modest activity increases and need less total volume to see benefit.

For older adults specifically, consistency seems to matter more than peak numbers. A daily 5,000-6,000 steps with decent cadence appears to do most of the heavy lifting, and pushing for 10,000 in an attempt to chase the younger-adult target can create joint stress without adding much longevity benefit.

For younger adults, the calculation is different but not hugely — extra steps above 8,000 produce diminishing returns rather than new benefit. You’re better off spending that time on sleep, strength training, or Zone 2 at a higher intensity.

Tracking accuracy (and why it matters less than you think)

People worry about whether their phone step count is accurate. A 2022 comparison study in JMIR mHealth and uHealth tested several consumer wearables against research-grade hip-worn accelerometers in controlled conditions and found they typically agreed within 5-10% for step counts — sometimes under-counting slow or shuffling movement, sometimes over-counting hand gestures, but broadly reliable for daily totals.

The practical implication is that a 500-step difference between your iPhone and your partner’s Apple Watch is meaningless noise. What matters is your own trend against your own device. If your average is drifting from 6,000 last month to 4,500 this month, something has changed in your life — and that’s worth paying attention to, regardless of whether the absolute numbers are perfect.

This is one of the reasons resting heart rate and step count make a useful pair in a longevity dashboard. One measures activity output, the other measures cardiovascular response to that activity, and trends in both tend to tell a coherent story about whether your fitness is improving or drifting.

A realistic target

If you asked me — and several people have — for a defensible number to aim for, I would say 7,000 steps at a decent pace on most days, with the caveat that anything above 4,000 is already buying you meaningful benefit. Under 60, you might nudge toward 8,000. Over 60, 6,000 is genuinely enough if the cadence is reasonable.

That’s it. That’s the target. It is less impressive than 10,000, less optimised than some corners of the longevity internet would like, and much more achievable for people who are not currently hitting anything close. Which, frankly, is the whole point — the research is clear that the biggest mortality wins come from dragging people off the lowest rungs of the activity ladder, not from squeezing more out of people who are already near the top.

The practical takeaway

The 10,000-step target is not wrong, it’s just arbitrary. You won’t harm yourself getting there, and if it motivates you to walk more, it’s doing its job. But if you’ve been quietly feeling guilty about averaging 6,500 steps per day, you can let that go. You’re in the middle of the dose-response curve where most of the benefit lives. Walk a bit faster, be consistent, and let the number be the number.

What Sarvita tracks alongside your step count — your resting heart rate, HRV, VO2 Max trend — will tell you whether the walking is actually working. Those are the signals to watch. The steps are just the input.

And the 10,000? It’s a pedometer that sold well in 1965. Nice round number. Decent logo. Not the law.